3ivq › Citations

Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases.

Zhuang M, Calabrese MF, Liu J, Waddell MB, Nourse A, Hammel M, Miller DJ, Walden H, Duda DM, Seyedin SN, Hoggard T, Harper JW, White KP, Schulman BA
Mol Cell 36 39-50 (2009)
Related entries: 3hqh, 3hqi, 3hql, 3hqm, 3hsv, 3htm, 3hu6, 3hve, 3ivv

Cited: 288 times
EuropePMC logo PMID: 19818708

Abstract

In the largest E3 ligase subfamily, Cul3 binds a BTB domain, and an associated protein-interaction domain such as MATH recruits substrates for ubiquitination. Here, we present biochemical and structural analyses of the MATH-BTB protein, SPOP. We define a SPOP-binding consensus (SBC) and determine structures revealing recognition of SBCs from the phosphatase Puc, the transcriptional regulator Ci, and the chromatin component MacroH2A. We identify a dimeric SPOP-Cul3 assembly involving a conserved helical structure C-terminal of BTB domains, which we call "3-box" due to its facilitating Cul3 binding and its resemblance to F-/SOCS-boxes in other cullin-based E3s. Structural flexibility between the substrate-binding MATH and Cul3-binding BTB/3-box domains potentially allows a SPOP dimer to engage multiple SBCs found within a single substrate, such as Puc. These studies provide a molecular understanding of how MATH-BTB proteins recruit substrates to Cul3 and how their dimerization and conformational variability may facilitate avid interactions with diverse substrates.

Articles - 3ivq mentioned but not cited (1)

  1. Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases. Zhuang M, Calabrese MF, Liu J, Waddell MB, Nourse A, Hammel M, Miller DJ, Walden H, Duda DM, Seyedin SN, Hoggard T, Harper JW, White KP, Schulman BA. Mol. Cell 36 39-50 (2009)


Reviews citing this publication (68)

  1. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution. Taguchi K, Motohashi H, Yamamoto M. Genes Cells 16 123-140 (2011)
  2. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway. Baird L, Yamamoto M. Mol Cell Biol 40 e00099-20 (2020)
  3. The cullin-RING ubiquitin-protein ligases. Hua Z, Vierstra RD. Annu Rev Plant Biol 62 299-334 (2011)
  4. The cullin protein family. Sarikas A, Hartmann T, Pan ZQ. Genome Biol. 12 220 (2011)
  5. Structural regulation of cullin-RING ubiquitin ligase complexes. Duda DM, Scott DC, Calabrese MF, Zimmerman ES, Zheng N, Schulman BA. Curr. Opin. Struct. Biol. 21 257-264 (2011)
  6. Mechanism and evolution of cytosolic Hedgehog signal transduction. Wilson CW, Chuang PT. Development 137 2079-2094 (2010)
  7. The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications. Genschik P, Sumara I, Lechner E. EMBO J. 32 2307-2320 (2013)
  8. Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy. Zhou W, Slingerland JM. Nat. Rev. Cancer 14 26-38 (2014)
  9. Ubiquitin Ligases: Structure, Function, and Regulation. Zheng N, Shabek N. Annu. Rev. Biochem. 86 129-157 (2017)
  10. The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation. Amin MB, Lin DW, Gore JL, Srigley JR, Samaratunga H, Egevad L, Rubin M, Nacey J, Carter HB, Klotz L, Sandler H, Zietman AL, Holden S, Montironi R, Humphrey PA, Evans AJ, Epstein JI, Delahunt B, McKenney JK, Berney D, Wheeler TM, Chinnaiyan AM, True L, Knudsen B, Hammond ME. Arch Pathol Lab Med 138 1387-1405 (2014)
  11. Structural basis of Keap1 interactions with Nrf2. Canning P, Sorrell FJ, Bullock AN. Free Radic. Biol. Med. 88 101-107 (2015)
  12. Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation. Bulatov E, Ciulli A. Biochem. J. 467 365-386 (2015)
  13. Quantifying ubiquitin signaling. Ordureau A, Münch C, Harper JW. Mol. Cell 58 660-676 (2015)
  14. SPOP and cancer: a systematic review. Clark A, Burleson M. Am J Cancer Res 10 704-726 (2020)
  15. Uncovering ubiquitin and ubiquitin-like signaling networks. Vertegaal AC. Chem. Rev. 111 7923-7940 (2011)
  16. Molecular genetics of prostate cancer: emerging appreciation of genetic complexity. Barbieri CE, Demichelis F, Rubin MA. Histopathology 60 187-198 (2012)
  17. Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants. Dinkova-Kostova AT, Kostov RV, Canning P. Arch. Biochem. Biophys. 617 84-93 (2017)
  18. Advancing targeted protein degradation for cancer therapy. Dale B, Cheng M, Park KS, Kaniskan HÜ, Xiong Y, Jin J. Nat Rev Cancer 21 638-654 (2021)
  19. Twists and turns in ubiquitin-like protein conjugation cascades. Schulman BA. Protein Sci. 20 1941-1954 (2011)
  20. The emerging role of speckle-type POZ protein (SPOP) in cancer development. Mani RS. Drug Discov. Today 19 1498-1502 (2014)
  21. The diverse roles of SPOP in prostate cancer and kidney cancer. Wang Z, Song Y, Ye M, Dai X, Zhu X, Wei W. Nat Rev Urol 17 339-350 (2020)
  22. Functional analysis of Cullin 3 E3 ligases in tumorigenesis. Cheng J, Guo J, Wang Z, North BJ, Tao K, Dai X, Wei W. Biochim Biophys Acta Rev Cancer 1869 11-28 (2018)
  23. NEDD8 and ubiquitin ligation by cullin-RING E3 ligases. Baek K, Scott DC, Schulman BA. Curr Opin Struct Biol 67 101-109 (2021)
  24. Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic Implications. Chen HY, Chen RH. Front Oncol 6 113 (2016)
  25. The role of natural products in revealing NRF2 function. Zhang DD, Chapman E. Nat Prod Rep 37 797-826 (2020)
  26. E3 Ubiquitin Ligases in Neurological Diseases: Focus on Gigaxonin and Autophagy. Lescouzères L, Bomont P. Front Physiol 11 1022 (2020)
  27. Genetics and genomics of prostate cancer. Dean M, Lou H. Asian J. Androl. 15 309-313 (2013)
  28. Cullin-RING Ubiquitin Ligase Regulatory Circuits: A Quarter Century Beyond the F-Box Hypothesis. Harper JW, Schulman BA. Annu Rev Biochem 90 403-429 (2021)
  29. Cullin-RING ubiquitin ligases in salicylic acid-mediated plant immune signaling. Furniss JJ, Spoel SH. Front Plant Sci 6 154 (2015)
  30. Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy. Hu X, Wang J, Chu M, Liu Y, Wang ZW, Zhu X. Mol Ther 29 908-919 (2021)
  31. Ubiquitin ligases in cancer: Functions and clinical potentials. Duan S, Pagano M. Cell Chem Biol 28 918-933 (2021)
  32. Control of craniofacial and brain development by Cullin3-RING ubiquitin ligases: Lessons from human disease genetics. Asmar AJ, Beck DB, Werner A. Exp Cell Res 396 112300 (2020)
  33. Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction. Nguyen HC, Wang W, Xiong Y. Subcell Biochem 83 323-347 (2017)
  34. The role of cullin proteins in gastric cancer. Chen P, Yao GD. Tumour Biol. 37 29-37 (2016)
  35. Cullin 3-Based Ubiquitin Ligases as Master Regulators of Mammalian Cell Differentiation. Dubiel W, Dubiel D, Wolf DA, Naumann M. Trends Biochem. Sci. 43 95-107 (2018)
  36. Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes. Jillson LK, Yette GA, Laajala TD, Tilley WD, Costello JC, Cramer SD. Cancers (Basel) 13 3272 (2021)
  37. Cul3-KLHL20 ubiquitin ligase: physiological functions, stress responses, and disease implications. Chen HY, Liu CC, Chen RH. Cell Div 11 5 (2016)
  38. Post-Translational Modifications of H2A Histone Variants and Their Role in Cancer. Corujo D, Buschbeck M. Cancers (Basel) 10 (2018)
  39. CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers. Waddell AR, Huang H, Liao D. Cancers (Basel) 13 2872 (2021)
  40. Functional roles of E3 ubiquitin ligases in prostate cancer. Zhao Y, Li J, Chen J, Ye M, Jin X. J Mol Med (Berl) 100 1125-1144 (2022)
  41. The Roles of SPOP in DNA Damage Response and DNA Replication. Maekawa M, Higashiyama S. Int J Mol Sci 21 E7293 (2020)
  42. Lessons from tissue compartment-specific analysis of androgen receptor alterations in prostate cancer. Daniel M, Dehm SM. J. Steroid Biochem. Mol. Biol. 166 28-37 (2017)
  43. Molecular Basis of Prostate Cancer and Natural Products as Potential Chemotherapeutic and Chemopreventive Agents. Bai B, Chen Q, Jing R, He X, Wang H, Ban Y, Ye Q, Xu W, Zheng C. Front Pharmacol 12 738235 (2021)
  44. Nrf2 in Cancer, Detoxifying Enzymes and Cell Death Programs. Jenkins T, Gouge J. Antioxidants (Basel) 10 1030 (2021)
  45. Regulation of Hedgehog Signal Transduction by Ubiquitination and Deubiquitination. Zhang Q, Jiang J. Int J Mol Sci 22 13338 (2021)
  46. The molecular biology and therapeutic potential of Nrf2 in leukemia. Khodakarami A, Adibfar S, Karpisheh V, Abolhasani S, Jalali P, Mohammadi H, Gholizadeh Navashenaq J, Hojjat-Farsangi M, Jadidi-Niaragh F. Cancer Cell Int 22 241 (2022)
  47. Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy. Jang SM, Redon CE, Aladjem MI. Front Mol Biosci 5 19 (2018)
  48. Molecular Underpinnings Governing Genetic Complexity of ETS-Fusion-Negative Prostate Cancer. Bhatia V, Ateeq B. Trends Mol Med 25 1024-1038 (2019)
  49. Negative Regulation of the Innate Immune Response through Proteasomal Degradation and Deubiquitination. Budroni V, Versteeg GA. Viruses 13 584 (2021)
  50. Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation. Márquez-Cantudo L, Ramos A, Coderch C, de Pascual-Teresa B. Molecules 26 5606 (2021)
  51. A Synopsis of Signaling Crosstalk of Pericytes and Endothelial Cells in Salivary Gland. Cucu I, Nicolescu MI. Dent J (Basel) 9 144 (2021)
  52. ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification. Wang CW, Chuang HC, Tan TH. J Biomed Sci 30 71 (2023)
  53. Biophysical insights into glucose-dependent transcriptional regulation by PDX1. Usher ET, Showalter SA. J Biol Chem 298 102623 (2022)
  54. CUL3 E3 ligases in plant development and environmental response. Ban Z, Estelle M. Nat Plants 7 6-16 (2021)
  55. Counting Degrons: Lessons From Multivalent Substrates for Targeted Protein Degradation. Okoye CN, Rowling PJE, Itzhaki LS, Lindon C. Front Physiol 13 913063 (2022)
  56. Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy. Jiang Y, Ni S, Xiao B, Jia L. Acta Pharm Sin B 13 4341-4372 (2023)
  57. Functional roles of Speckle-Type Poz (SPOP) Protein in Genomic stability. Wei X, Fried J, Li Y, Hu L, Gao M, Zhang S, Xu B. J Cancer 9 3257-3262 (2018)
  58. Intracellular Communication among Morphogen Signaling Pathways during Vertebrate Body Plan Formation. Takebayashi-Suzuki K, Suzuki A. Genes (Basel) 11 (2020)
  59. Intrinsic Disorder in Plant Transcription Factor Systems: Functional Implications. Salladini E, Jørgensen MLM, Theisen FF, Skriver K. Int J Mol Sci 21 E9755 (2020)
  60. KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders. Teng X, Aouacheria A, Lionnard L, Metz KA, Soane L, Kamiya A, Hardwick JM. CNS Neurosci Ther 25 887-902 (2019)
  61. KLHL6 is a tumor suppressor gene in diffuse large B-cell lymphoma. Choi J, Zhou N, Busino L. Cell Cycle 18 249-256 (2019)
  62. Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease. Wang Y, Sui Z, Wang M, Liu P. Front Immunol 14 1196016 (2023)
  63. Prostate Cancer Epigenetic Plasticity and Enhancer Heterogeneity: Molecular Causes, Consequences and Clinical Implications. Kneppers J, Bergman AM, Zwart W. Adv Exp Med Biol 1390 255-275 (2022)
  64. RING-finger E3 ligases regulatory network in PI3K/AKT-mediated glucose metabolism. Wang W, Shi B, Cong R, Hao M, Peng Y, Yang H, Song J, Feng D, Zhang N, Li D. Cell Death Discov 8 372 (2022)
  65. SPOP and CUL3 Modulate the Sonic Hedgehog Signal Response Through Controlled Degradation of GLI Family Transcription Factors. Umberger PA, Ogden SK. Front Cell Dev Biol 9 710295 (2021)
  66. SPOP in Cancer: Phenomena, Mechanisms and Its Role in Therapeutic Implications. Yang X, Zhu Q. Genes (Basel) 13 2051 (2022)
  67. The emerging role of SPOP protein in tumorigenesis and cancer therapy. Song Y, Xu Y, Pan C, Yan L, Wang ZW, Zhu X. Mol. Cancer 19 2 (2020)
  68. The ubiquitin ligase adaptor SPOP in cancer. Cuneo MJ, Mittag T. FEBS J. 286 3946-3958 (2019)

Articles citing this publication (219)



Quick links